ea0090ep532 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023
, Dedecjus Marek
GLP-1 receptor agonists have become an important group of drugs used in the treatment of type 2 diabetes and then obesity. There are also many reports of very beneficial effects, e.g. in the treatment of polycystic ovary syndrome. Multidirectional metabolic impact, weight loss, menstrual regularity, and therefore fertility, when used in a group of young women, the possibility of pregnancy should always be taken. We present a case report of the patient which is the starting poi...